Treatment of growth hormone insensitivity syndrome (GHIS) with insulin-like growth factor (IGF-I). (Q41148789)

27 September 2017

1 reference

title

Treatment of growth hormone insensitivity syndrome (GHIS) with insulin-like growth factor (IGF-I). (English)

1 reference

growth hormone insensitivity syndrome

27 September 2017

main subject

1 reference

Ranke MB

1

1 reference

27 September 2017

publication date

1 July 1996

1 reference

Bailliere's clinical endocrinology and metabolism

27 September 2017

published in

1 reference

27 September 2017

volume

10

1 reference

27 September 2017

issue

3

1 reference

27 September 2017

page(s)

401-410

1 reference

Insulin-like growth factor-I (IGF-I) infusion into hypophysectomized or protein-deprived rats induces specific IGF-binding proteins in serum

27 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2896%2980530-1

7 January 2021

Growth hormone receptor deficiency (Laron syndrome): clinical and genetic characteristics

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2896%2980530-1

7 January 2021

Short-term metabolic effects of recombinant human insulin-like growth factor I in healthy adults

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2896%2980530-1

7 January 2021

Laron syndrome: clinical features, molecular pathology and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2896%2980530-1

7 January 2021

Effects of insulin-like growth factor on linear growth, head circumference, and body fat in patients with Laron-type dwarfism

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2896%2980530-1

7 January 2021

Classification of growth hormone insensitivity syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2896%2980530-1

7 January 2021

Growth curves for Laron syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2896%2980530-1

7 January 2021

Growth hormone, insulin-like growth factor I, and benign intracranial hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2896%2980530-1

7 January 2021

Adverse events during treatment with recombinant insulin-like growth factor I in patients with growth hormone insensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2896%2980530-1

7 January 2021

Insulin-like growth factor I improves height in growth hormone insensitivity: two years' results

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2896%2980530-1

7 January 2021

Stimulation of statural growth by recombinant insulin-like growth factor I in a child with growth hormone insensitivity syndrome (Laron type)

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2896%2980530-1

7 January 2021

Effect of trypsin treatment of rat adipocytes on biological effects and binding of insulin and insulin-like growth factors: further evidence for the action of insulin-like growth factors through the insulin receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2896%2980530-1

7 January 2021

10.1016/S0950-351X(96)80530-1

Identifiers

DOI

1 reference

release_t6x7adjbmnaopmbqhlj3g7weya

27 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/t6x7adjbmnaopmbqhlj3g7weya

24 November 2022

mapped directly with Wikidata item

1 reference